Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clomiphene citrate protocols with or without phytoestrogen in women with polycystic ovary syndrome
PACTR202204757658869Not yet recruiting
- Sponsor
- October 6 University
- Start
- Apr 2022
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of clomiphene and human chorionic gonadotropin in polycystic ovary syndrome (PCOS) and female infertility (3 arms), sponsored by October 6 University. Primary endpoint: Endometrial thickness at the day of hCG trigger. Planned start Apr 2022; status: not yet recruiting.
02
Drugs
clomiphenehuman chorionic gonadotropin
03
Conditions
polycystic ovary syndrome (PCOS)female infertility
Beyond the preview
Go deeper on PACTR202204757658869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202204757658869.